Forte Biosciences, Inc. · NASDAQ:FBRX
Federated Hermes, Inc. reported a 10.31% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 8, 2026
Federated Hermes, Inc. reported a 10.31% stake in Forte Biosciences, Inc., 2,110,516 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).
- Stake
- 10.31%
- Shares
- 2,110,516
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Federated Hermes, Inc. | 10.31% | 2,110,516 |
| Voting Shares Irrevocable Trust | 10.31% | 2,110,516 |
| Thomas R. Donahue | 10.31% | 2,110,516 |
| Ann C. Donahue | 10.31% | 2,110,516 |
| J. Christopher Donahue | 10.31% | 2,110,516 |
Source
Related
- Forte Biosciences, Inc.
- Federated Hermes, Inc.
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Oct 7, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 5, 2025
- Schedule 13G · Federated Hermes, Inc. · Jul 8, 2025
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026